Skip to search formSkip to main contentSkip to account menu

ONO 1101

Known as: ONO-1101 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

landiolol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
The effects of a new ultra-short-acting β-adrenergic blocker, ONO-1101, on cardiac function during and after cardiopulmonary bypass
The administration of an ultra-short-acting β-adrenergic antagonist, esmolol, has been introduced as a novel method for beating… 
Highly Cited
1999
Highly Cited
1999
Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol.
The purpose of this study was to assess the cardiovascular effects of an ultra-short-acting beta-blocker, ONO-1101, by using… 
1999
1999
Landiolol decreases a dysrhythmogenic dose of epinephrine in dogs during halothane anesthesia
PurposeTo examine the effect of landiolol (ONO-1101), a new ultra-short acting and highly selective beta, blocker, on epinephrine… 
1998
1998
Time course of a new ultrashort-acting beta-adrenoceptor-blocking drug, ONO-1101: comparison with those of esmolol and propranolol by using the canine isolated, blood-perfused heart preparations.
Time courses of beta-adrenoceptor-blocking actions of ONO-1101, a new cardioselective beta-blocker, were compared with those of… 
1998
1998
Effect of ONO-1101, a novel short-acting β-blocker on hemodynamic responses to isoflurane inhalation and tracheal intubation
PurposeWe investigated the effect of a new ultrashort-acting β-blocker, ONO-1101, on hemodynamic responses to isoflurane… 
1997
1997
Efficacy of an ultrashort-acting β-adrenoceptor blocker (ONO-1101) in attenuating cardiovascular responses to endotracheal intubation
AbstractObjective: To investigate the clinical effectiveness and safety of ONO-1101, a new ultrashort-acting (half-life 3–4 min… 
1997
1997
[Reproductive and developmental toxicity studies of landiolol hydrochloride (ONO-1101) (4). Perinatal and postnatal study in rats].
A perinatal and postnatal study of landiolol hydrochloride (ONO-1101), a novel ultra short acting beta-blocker, was conducted in… 
1997
1997
REPRODUCTIVE AND DEVELOPMENTAL TOXICITY STUDIES OF LANDIOLOL HYDROCHLORIDE (ONO-1101) (3) TERATOGENICITY STUDY IN RABBITS
A teratogenicity study of landiolol hydrochloride (ONO-1101), a novel ultra short acting β-blocker, was conducted in Sprague… 
1996
1996
Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
Direct effects of ONO-1101 ¿(-)-[(S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl-3-[4-[(S) -2-hydroxy-3-(2-morpholino carbonylamino… 
Highly Cited
1992
Highly Cited
1992
Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101.
A novel, highly cardioselective ultra short-acting beta-blocker, ONO-1101, has been developed for application in the emergency… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)